Skip to main content

Table 3 Scoring of GI and GU disorders for WP and PO 3DCRT techniques.

From: The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques

Incidence and development of acute GI/GU toxicity from pretreatment symptoms

  

Acute GI toxicity

Acute GU toxicity

  

WP

PO

WP

PO

Pretreatment

Symptoms

Acute toxicity

n

%

n

%

n

%

n

%

0 → 0

33

28.45%

40

49.38%

43

37.07%

36

44.44%

0 → 1

14

12.07%

17

20.99%

18

15.52%

12

14.81%

0 → 2

58

50.00%

20

24.69%

25

21.55%

17

20.99%

0 → 3

1

0.86%

  

1

0.86%

  

1 → 0

  

1

1.23%

13

11.21%

7

8.64%

1 → 1

  

2

2.47%

6

5.17%

3

3.70%

1 → 2

5

4.31%

1

1.23%

4

3.45%

3

3.70%

1 → 3

2

1.72%

      

2 → 0

1

0.86%

  

1

0.86%

1

1.23%

2 → 1

      

1

1.23%

2 → 2

1

0.86%

  

1

0.86%

  

2 → 3

    

2

1.72%

1

1.23%

3 → 0

    

1

0.86%

  

3 → 1

        

3 → 2

1

0.72%

      

3 → 3

    

1

0.86%

  

Development of late GI/GU toxicity from acute GI/GU toxicity

  

GI toxicity

GU toxicity

  

WP

PO

WP

PO

Acute toxicity

Late toxicity

n

%

n

%

n

%

n

%

0 → 0

29

25.00%

34

41.98%

41

35.34%

31

38.27%

0 → 1

5

4.31%

5

6.17%

13

11.21%

8

9.88%

0 → 2

  

2

2.47%

1

0.86%

3

3.70%

0 → 3

1

0.86%

  

3

2.59%

2

2.47%

1 → 0

10

8.62%

11

13.58%

17

14.66%

9

11.11%

1 → 1

4

3.45%

7

8.64%

4

3.45%

2

2.47%

1 → 2

    

1

0.86%

2

2.47%

1 → 3

  

1

1.23%

2

1.72%

3

3.70%

2 → 0

47

40.52%

9

11.11%

18

15.52%

10

12.35%

2 → 1

9

7.76%

6

7.41%

8

6.90%

8

9.88%

2 → 2

5

4.31%

5

6.17%

3

2.59%

2

2.47%

2 → 3

2

1.72%

1

1.23%

1

0.86%

  

2 → 4

1

0.86%

      

3 → 0

2

1.72%

      

3 → 1

1

0.86%

  

2

1.72%

  

3 → 2

    

1

0.86%

  

3 → 3

    

1

0.86%

1

1.23%

Summary of last late GI/GU toxicities dynamics

      

WP

PO

Last late GI toxicity

n

%

n

%

Patients without toxicity

29

25.00%

34

41.98%

Decrease of toxicity (G1,2,3→G0)

59

50.86%

20

24.69%

Patients with moderate toxicity-G1

    

   Development G0 → G1

5

4.31%

5

6.17%

   Unchanged grade of toxicity G1

4

3.45%

7

8.64%

   Decrease of toxicity from G2, 3→ G1

10

8.62%

6

7.41%

Patients with high level toxicity G2, 3, 4

9

7.76%

9

11.11%

      

WP

PO

Last late GU toxicity

n

%

n

%

Patients without toxicity

41

35.34%

31

38.27%

Decrease of toxicity (G1,2,3 → G0)

35

30.17%

19

23.46%

Patients with moderate toxicity-G1

    

   Development G0 → G1

13

11.21%

8

9.88%

   Unchanged grade of toxicity G1

4

3.45%

2

2.47%

   Decrease of toxicity from G2, 3→G1

10

8.62%

8

9.88%

Patients with high level toxicity G2, 3, 4

13

11.21%

13

16.05%